A First-in-human Study of ILDR2 (Immunoglobulin-like Domain Containing Receptor 2) Function-blocking Antibody BAY1905254

Condition:   Advanced Solid Tumor
Intervention:   Drug: BAY1905254
Sponsor:   Bayer
Not yet recruiting

https://ift.tt/2x1G9rJ